BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31358384)

  • 1. Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
    Genitsch V; Kollár A; Vandekerkhove G; Blarer J; Furrer M; Annala M; Herberts C; Pycha A; de Jong JJ; Liu Y; Krentel F; Davicioni E; Gibb EA; Kruithof-de Julio M; Wyatt AW; Seiler R
    Urol Oncol; 2019 Sep; 37(9):573.e19-573.e29. PubMed ID: 31358384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
    Genitsch V; Kollár A; Vandekerkhove G; Blarer J; Furrer M; Annala M; Herberts C; Pycha A; de Jong JJ; Liu Y; Krentel F; Davicioni E; Gibb EA; Kruithof-de Julio M; Wyatt AW; Seiler R
    Urol Oncol; 2019 Nov; 37(11):826-836. PubMed ID: 31585777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcomatoid Urothelial Carcinoma of the Bladder: Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition.
    Sanfrancesco J; McKenney JK; Leivo MZ; Gupta S; Elson P; Hansel DE
    Arch Pathol Lab Med; 2016 Jun; 140(6):543-51. PubMed ID: 27031776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors.
    Tan TZ; Rouanne M; Tan KT; Huang RY; Thiery JP
    Eur Urol; 2019 Mar; 75(3):423-432. PubMed ID: 30213523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive urothelial carcinoma with chordoid features may be an ominous sign predicting sarcomatoid change: a case report of a bladder carcinoma.
    Tajima S; Suzuki T; Yamada Y; Morikawa T; Minagawa D; Homma Y; Fukayama M
    Med Mol Morphol; 2016 Sep; 49(3):182-7. PubMed ID: 25690253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcomatoid carcinoma associated with small cell carcinoma of the urinary bladder: a series of 28 cases.
    Urrea YR; Epstein JI
    Hum Pathol; 2017 Sep; 67():169-175. PubMed ID: 28827101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Sarcomatoid Tumor of the Bladder: A Different Entity but the Same Approach?
    Molina-Cerrillo J; Martínez-Sáez O; Alonso-Gordoa T; Tirado-Zambrano P; Delgado-Vargas B; Earl J; Grande E
    Clin Genitourin Cancer; 2015 Dec; 13(6):493-8. PubMed ID: 26027772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TERT promoter mutation analysis as a surrogate to morphology and immunohistochemistry in problematic spindle cell lesions of the urinary bladder.
    Bertz S; Stöhr R; Gaisa NT; Wullich B; Hartmann A; Agaimy A
    Histopathology; 2020 Dec; 77(6):949-962. PubMed ID: 32645760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudoangiosarcomatous urothelial carcinoma of the urinary bladder.
    Paner GP; Cox RM; Richards K; Akki A; Gokden N; Lopez-Beltran A; Krausz T; McKenney JK; Steinberg GD
    Am J Surg Pathol; 2014 Sep; 38(9):1251-9. PubMed ID: 25133708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Expression Profiling of Muscle-Invasive Bladder Cancer With Secondary Variant Histology.
    de Jong JJ; Narayan VM; Cronican AA; Gupta S; van Leenders GJLH; Boormans JL; Gibb EA; Konety BR
    Am J Clin Pathol; 2021 Oct; 156(5):895-905. PubMed ID: 34157072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
    Manzano RG; Catalan-Latorre A; Brugarolas A
    BMC Cancer; 2021 Apr; 21(1):432. PubMed ID: 33879103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA3 expression in sarcomatoid urothelial carcinoma of the bladder.
    Fatima N; Osunkoya AO
    Hum Pathol; 2014 Aug; 45(8):1625-9. PubMed ID: 24824028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis.
    Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L
    Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer.
    Guo CC; Majewski T; Zhang L; Yao H; Bondaruk J; Wang Y; Zhang S; Wang Z; Lee JG; Lee S; Cogdell D; Zhang M; Wei P; Grossman HB; Kamat A; Duplisea JJ; Ferguson JE; Huang H; Dadhania V; Gao J; Dinney C; Weinstein JN; Baggerly K; McConkey D; Czerniak B
    Cell Rep; 2019 May; 27(6):1781-1793.e4. PubMed ID: 31067463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Pathologic Subtyping of Urothelial Bladder Carcinoma in Young Patients.
    Shelekhova KV; Krykow KA; Mescherjakov IA; Mitin NP
    Int J Surg Pathol; 2019 Aug; 27(5):483-491. PubMed ID: 30854907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolution of bladder cancer genomics: What have we learned and how can we use it?
    Audenet F; Attalla K; Sfakianos JP
    Urol Oncol; 2018 Jul; 36(7):313-320. PubMed ID: 29573965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial Histotypes.
    Hoffman-Censits JH; Lombardo KA; Parimi V; Kamanda S; Choi W; Hahn NM; McConkey DJ; McGuire BM; Bivalacqua TJ; Kates M; Matoso A
    Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):619-625. PubMed ID: 33901032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yolk sac differentiation in urothelial carcinoma - A rare variant originating from aberrant differentiation of sarcomatoid components.
    Krishnamurthy K; Rosen S; Ye H; Sun Y
    Ann Diagn Pathol; 2022 Jun; 58():151923. PubMed ID: 35180608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of prominent retraction clefts in invasive urothelial carcinoma.
    Shah TS; Kaag M; Raman JD; Chan W; Tran T; Kunchala S; Shuman L; DeGraff DJ; Chen G; Warrick JI
    Hum Pathol; 2017 Mar; 61():90-96. PubMed ID: 27818288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.